CorVista wins FDA clearance for AI heart failure assessment add-on
July 29, 2026
CorVista’s AI-based pulmonary capillary wedge pressure add-on test represents the third FDA clearance for its cardiopulmonary platform.
CorVista’s AI-based pulmonary capillary wedge pressure add-on test represents the third FDA clearance for its cardiopulmonary platform.
Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.
Smith+Nephew (NYSE:SNN) announced today that the FDA granted de novo clearance for its TESSA spatial surgery system.
Deep wounds are vulnerable to bacterial infection and the accumulation of harmful molecules called reactive oxygen species (ROS), which damage cells and disrupt normal repair mechanisms.
Wearable health monitors have grown increasingly capable, but most are still limited by the fact that tracking different types of body signals requires separate sensors, each with its own circuitry and patch of skin. That leads to bulkier devices, higher power consumption and greater discomfort for anyone who needs round-the-clock monitoring.
Biosensors have revolutionized home health care over the past two decades. Devices like wearable heart rate and blood glucose monitors are giving people with chronic health conditions the information and assurance they need to maintain an active lifestyle. But even the best sensors are limited by their ability to sustain skin contact through the rigors of physical activity.
The PicoPretty device seamlessly integrates Picosecond, Long Pulse, and Genesis technologies to provide unparalleled versatility
With regulatory clearance in place, FIZE Medical expands its global commercial footprint across Europe and the UK alongside existing operations in North America and Japan
A research team at The University of Hong Kong (HKU), has developed ClairS—a deep-learning algorithm that significantly improves the detection of cancer mutations using long-read sequencing. Tested on breast cancer, lung cancer and melanoma cell line datasets, ClairS has demonstrated high accuracy across various cancer types and sequencing conditions.
A bioinspired material developed by scientists at Imperial College London accelerates wound healing and the repair of human skin. The material captures the body’s own healing proteins, releasing them only when repair cells pull on them and delivering healing signals precisely where and when they are needed.